Vb-201 160mg    (DrugBank: VB-201)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis1

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01839214
(ClinicalTrials.gov)
January 201321/4/2013A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative ColitisA Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects With Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: VB-201 160mg;Drug: PlaceboVascular Biogenics Ltd. operating as VBL TherapeuticsNULLCompleted18 YearsN/ABoth112Phase 2Bulgaria;Hungary;Poland